Abstract: The present invention relates to a pharmaceutical composition for the treatment of neuroinflammation including eleutheroside B as an active ingredient, and more particularly, to a pharmaceutical composition for treating neuroinflammatory disease in patients with the increased activity of astrocytes or microglia, comprising eleutheroside B or a pharmaceutically acceptable salt thereof as an active ingredient.

Abstract: A method of controlling a display device includes rendering a plurality of viewpoint images, generating a plurality of sub-images based on the plurality of viewpoint images and a plurality of mapping pattern images corresponding to the plurality of viewpoint images, generating a single light-field image based on the plurality of sub-images, and outputting the single light-field image.

Abstract: Provided are a negative electrode for a lithium secondary battery and a method of manufacturing the same. The negative electrode for a lithium secondary battery according to an embodiment of the present invention includes a negative electrode active material including: a silicon oxide, lithium, and sodium or potassium, wherein in ICP analysis of a negative electrode active material layer including the negative electrode active material, contents of elements in the negative electrode active material layer satisfy the following Relations (1) and (2): 300?106*A/(B2+C2)?12.0*106??(1) 800?A?140,000??(2) wherein A is a Li content in ppm, B is a Na content in ppm, and C is a K content in ppm, based on the total weight of the ICP-analyzed negative electrode active material layer.

Abstract: Provided is a genome extraction device to which a dual chamber structure of an outer chamber and a bead chamber is applied, more particularly a genome extraction device to which the above-described dual chamber structure is applied so that the performance of dry beads vulnerable to moisture can be maintained for a long time.

Abstract: There are provided a memory device and a manufacturing method of the memory device. The memory device includes: a first stack structure including a word line of a first group and select lines of a first group; a second stack structure including select lines of a second group; a first plug in the first stack structure; a second plug connected to the first plug, the second plug being disposed in the second stack structure; a first isolation pattern between the select lines of the first group; and a second isolation pattern between the select lines of the second group.

Abstract: An apparatus for controlling a transmission of a vehicle includes a determination device that determines whether a condition for a regenerative braking based lift foot up shift is satisfied, a controller that performs regenerative brake control and performs a shift by controlling release clutch torque and lock-up clutch torque, when the condition for the regenerative braking based lift foot up shift is satisfied, and a torque compensation device that compensates for the release clutch torque according to an RPM variation during the shift.

Abstract: According to an embodiment of the present disclosure, a cordless hair straightener includes a body which includes a battery including an input and an output and charged by an external power supply through the input, a first heater unit and a second heater unit which are electrically connected to the output of the battery, a first housing which accommodates at least a part of the body and at least a part of the first heater unit therein and moves the first heater unit between a closed position and an open position, and a second housing which accommodates at least a part of the body and at least a part of the second heater unit therein and moves the second heater unit between a closed position and an open position.

Abstract: The invention relates to a drag device for a fishing reel using fluid resistance, comprising: a housing (3) constituting an outer body; a resistance fluid filled in a hydraulic chamber (C) in the housing (3); rotary blades (5) rotatably built in the hydraulic chamber (C) together with the resistance fluid; and a rotary shaft (7) rotatably supported by the housing (3) so as to rotatably support the rotary blades (5) in the hydraulic chamber (C), wherein when a rotational torque greater than a preset torque is applied to a spool (10) of the fishing reel shaft-coupled to the rotary shaft (7), the rotary blades (5) are configured to rotate in a direction that unwinds a fishing line together with the spool (10) while overcoming the fluid resistance of the resistance fluid.

Abstract: A method of controlling vehicle braking includes decelerating a vehicle to a first speed by using regenerative braking when a vehicle stop request is generated by a manipulation of a paddle shifter, stopping the vehicle by using hydraulic braking when the vehicle is decelerated to the first speed, and maintaining a stopped state of the vehicle by automatic vehicle hold control when the vehicle is stopped.

Abstract: A gas leak detecting method includes a test article preparation operation of preparing a test article that includes a first coupling region, in which a second component is coupled to one side of a first component, and a second coupling region, in which a third component is coupled to one side of the second component, a test article arrangement operation of arranging the test article in an inner space of a body unit, and a sealing inspection operation of examining a gas discharged from the inner space and inspecting whether or not the first coupling region or the second coupling region is sealed. In the test article arrangement operation, each of the first coupling region and the second coupling region is located inside the inner space.

Abstract: Disclosed is an organic light emitting display having reduced thickness and weight. The organic light emitting display with a touch sensor removes the necessity of an additional adhesion process by directly forming a touch sensor including a touch sensing line and a touch driving line and a color filter on the encapsulation layer covering a light emitting device, thereby simplifying a manufacturing process and reducing manufacturing costs.

Abstract: A liquid crystal composition for a display device, the composition includes compounds of Chemical Formulae 1-7 with the amounts and compounds defined herein.

Abstract: Disclosed is an organic light emitting display having reduced thickness and weight. The organic light emitting display with a touch sensor removes the necessity of an additional adhesion process by directly forming a touch sensor including a touch sensing line and a touch driving line and a color filter on the encapsulation layer covering a light emitting device, thereby simplifying a manufacturing process and reducing manufacturing costs.

Abstract: The present invention relates to a polypeptide including an Fc variant produced by substituting a portion of the amino acid sequence of the Fc domain of a human antibody with a different amino acid sequence. The present invention also relates to an antibody including the polypeptide. The Fc variant can find application in a wide range of antibodies and Fc-fusion constructs. In one aspect, the antibody or Fc fusion construct of the present invention is a therapeutic, diagnostic or laboratory reagent, preferably a therapeutic reagent. The Fc variant is suitable for use in the treatment of cancer because its in vivo half-life can be maximized by optimization of the portion of the amino acid sequence. The antibody or Fc fusion construct of the present invention is used to kill target cells that bear a target antigen, for example cancer cells. Alternatively, the antibody or Fc fusion construct of the present invention is used to block, antagonize or agonize a target antigen.

Abstract: The present invention relates to a novel quercetin derivative compound and to a use thereof. More specifically, the present invention relates to a novel quercetin derivative compound having inhibitory activity against bromodomain extra-terminal (BET) proteins, and to a pharmaceutical composition for preventing or treating BET protein-related diseases, comprising the same.

Abstract: A regenerative braking control system of an AWD (all-wheel-drive) hybrid vehicle including a front wheel HEV (hybrid electric vehicle) powertrain and a rear wheel EV (electric vehicle) powertrain is provided. The control system includes a manipulating instrument mounted to a steering wheel for manual shifting and regenerative braking control by a driver's manipulation, and a controller for adjusting a regenerative braking amount and controlling a shift pattern of each of a front wheel motor of the front wheel HEV powertrain and a rear wheel motor of the rear wheel EV powertrain by receiving a (?) or (+) manipulation signal or a hold manipulation signal of the manipulating instrument.

Abstract: A regenerative braking control system and a regenerative braking control method using a paddle shift of a hybrid vehicle, include a paddle switch including a first paddle shift for a down shift and a second paddle shift for an up shift, a first controller electrically connected to the paddle switch and configured to determine a deceleration control amount of regenerative braking for stopping the vehicle as a hold operation of the first paddle shift is input, and a second controller electrically connected to the first controller and configured to control a motor torque for the regenerative braking according to the deceleration control amount determined from the first controller and to control hydraulic braking of the vehicle to be executed when reaching a stop state of the vehicle.

Abstract: The present invention relates to a polypeptide including an Fc variant produced by substituting a portion of the amino acid sequence of the Fc domain of a human antibody with a different amino acid sequence. The present invention also relates to an antibody including the polypeptide. The Fc variant can find application in a wide range of antibodies and Fc-fusion constructs. In one aspect, the antibody or Fc fusion construct of the present invention is a therapeutic, diagnostic or laboratory reagent, preferably a therapeutic reagent. The Fc variant is suitable for use in the treatment of cancer because its in vivo half-life can be maximized by optimization of the portion of the amino acid sequence. The antibody or Fc fusion construct of the present invention is used to kill target cells that bear a target antigen, for example cancer cells. Alternatively, the antibody or Fc fusion construct of the present invention is used to block, antagonize or agonize a target antigen.

Abstract: A liquid crystal composition includes the following compounds: (in a range of 21.5 to 26.5 parts by weight) a compound represented by a first chemical formula, (in a range of 2.5 to 7.5 parts by weight) a compound represented by a second chemical formula, (in a range of 12.5 to 17.5 parts by weight) a compound represented by a third chemical formula, (in a range of 5.5 to 10.5 parts by weight) a compound represented by a fourth chemical formula, (in a range of 7.5 to 12.5 parts by weight) a compound represented by a fifth chemical formula, (in a range of 2 to 7 parts by weight) a compound represented by a sixth chemical formula, (in a range of 10.5 to 15.5 parts by weight) a compound represented by a seventh chemical formula, and (in a range of 13 to 18 parts by weight) an compound represented by an eighth chemical formula 8.